miR-552在恶性肿瘤中的研究进展

ISSN:2705-098X(P)

EISSN:2705-0505(O)

语言:中文

作者
黄 鑫,莫军扬
文章摘要
恶性肿瘤对人类健康构成严重威胁,其诊治成为医学领域亟待解决的重大挑战。microRNA在肿瘤发生的调节机制中起着关键作用,包括参与细胞增殖、分化、凋亡等生物学活动。研究表明,miR-552在多种恶性肿瘤中表达异常,通过调控靶基因,在恶性肿瘤发生发展起到关键影响。本文旨在系统梳理和总结miR-552在多种人类恶性肿瘤中的表达特点及其在肿瘤发展过程中的作用,以期为恶性肿瘤的防治提供更为坚实的科学依据。
文章关键词
微小RNA;miR-552;恶性肿瘤
参考文献
[1] 黄永塔,莫祥兰.miRNA与肿瘤转移调控机制的研究进展[J].中国临床新医学,2020,13(01):94-98. [2] 张涛,周斌.miR-552-3p对非小细胞肺癌细胞增殖、迁移及侵袭的影响及其调控Wnt信号通路的机制[J].临床医学研究与实践,2021,6(32):8-10. [3] 李猛,仲雅婷,陈成,等.miR-552和miR-592在胃癌组织中的表达及其与临床病理特征的关系[J].胃肠病学和肝病学杂志,2021,30(10):1096-1100. [4] 王娜.miR-552在结肠癌中的表达及其临床意义研究[D].河北医科大学,2018. [5] 李想才.结直肠肿瘤中miR-552和miR-592的表达[D].广州医科大学,2019. [6] 左婷婷,郑荣寿,曾红梅,等.中国胃癌流行病学现状[J].中国肿瘤临床,2017,44(01):52-58. [7] FENG X,ZHU M,LIAO B,et al.Upregulation of miR-552 Predicts Unfavorable Prognosis of Gastric Cancer and Promotes the Proliferation,Migration,and Invasion of Gastric Cancer Cells.[J].ONCOL RES TREAT,2020,43(3):103-111. [8] ZHAO Y,ZHANG J,YANG W,et al.MicroRNA-552 Accelerates the Progression of Gastric Cancer by Targeting FOXO1 and Regulating PI3K/AKT Pathway.[J].J ONCOL,2021,2021(null):9966744. [9] ZHU L,ZHANG S,CHEN S,et al.Exosomal miR-552-5p promotes tumorigenesis and disease progression via the PTEN/TOB1 axis in gastric cancer.[J].J Cancer,2022,13(3):890-905. [10] 周雄,胡明,李子帅,等.2020年全球及中国结直肠癌流行状况分析[J].海军军医大学学报,2022,43(12):1356-1364. [11] WANG N,LIU W.Increased expression of miR-552 acts as a potential predictor biomarker for poor prognosis of colorectal cancer.[J].EUR REV MED PHARMACO,2018,22(2):412-416. [12] IM J,NAM S K,LEE H S.MicroRNA-552 expression in colorectal cancer and its clinicopathological significance.[J].J PATHOL TRANSL MED,2021,55(2):125-131. [13] WANG J,LI H,WANG Y,et al.MicroRNA-552 enhances metastatic capacity of colorectal cancer cells by targeting a disintegrin and metalloprotease 28.[J].Oncotarget,2016,7(43):70194-70210. [14] CAO J,YAN X R,LIU T,et al.MicroRNA-552 promotes tumor cell proliferation and migration by directly targeting DACH1 via the Wnt/β-catenin signaling pathway in colorectal cancer.[J].ONCOL LETT,2017,14(3):3795-3802. [15] COMMISSION GENERAL OFFICE OF NATIONAL.胰腺癌诊疗指南(2022年版)[J].临床肝胆病杂志,2022,38(05):1006-1030. [16] WANG X,DOU N,WANG J,et al.FOXM1-induced miR-552 expression contributes to pancreatic cancer progression by targeting multiple tumor suppressor genes.[Z].2021:17,915-925. [17] PEOPLE NATIONAL HEALTH COMMISSION OF,CHINA S.REPUBLIC OF.原发性肝癌诊疗指南(2022年版)[J].肿瘤综合治疗电子杂志,2022,8(02):16-53. [18] HAN T,ZHANG Y,YANG X,et al.miR-552 Regulates Liver Tumor-Initiating Cell Expansion and Sorafenib Resistance.[J].Mol Ther Nucleic Acids,2020,19(null):1073-1085. [19] QU W,WEN X,SU K,et al.MiR-552 promotes the proliferation,migration and EMT of hepatocellular carcinoma cells by inhibiting AJAP1 expression.[J].J CELL MOL MED,2019,23(2):1541-1552. [20] MA Y,MA M,MA L,et al.Downregulation of miR-552 in hepatocellular carcinoma inhibits cell migration and invasion,and promotes cell apoptosis via RUNX3.[J].EXP THER MED,2019,18(5):3829-3836. [21] LI C,WANG Z,CHEN S,et al.MicroRNA-552 promotes hepatocellular carcinoma progression by downregulating WIF1.[J].INT J MOL MED,2018,42(6):3309-3317. [22] 陈文杰,王斌全,高伟,等.喉癌流行病学特征及影响因素分析[J].中国当代医药,2015,22(12):43-46. [23] GU J,HAN T,SUN L,et al.miR-552 promotes laryngocarcinoma cells proliferation and metastasis by targeting p53 pathway.[Z].2020:19,1012-1021. [24] LIU L,JIA Q,WANG J,et al.Exosome miR-552 Promotes Laryngocarcinoma Cells Malignant Progression via the PTEN/TOB1 Axis.[J].PHARMACOLOGY,2023,null(null):1-10. [25] 赵虹琳,李婷婷,丁国武.1990-2019年中国女性卵巢癌疾病负担趋势分析[J].中华肿瘤防治杂志,2023,30(09):507-512. [26] ZHAO W,HAN T,LI B,et al.miR-552 promotes ovarian cancer progression by regulating PTEN pathway.[J].J Ovarian Res,2019,12(1):121. [27] WANG L,WANG H,CHEN J.Linc00261 Inhibited High-Grade Serous Ovarian Cancer Progression through miR-552-ATG10-EMT Axis.[J].COMPUT MATH METHOD M,2022,2022(null):9450353. [28] 罗年安,屈亚琦,董瑞.乳腺癌的治疗进展[J].现代生物医学进展,2015,15(01):160-162. [29] JIANG B,XIA J,ZHOU X.Overexpression of lncRNA SLC16A1-AS1 Suppresses the Growth and Metastasis of Breast Cancer via the miR-552-5p/WIF1 Signaling Pathway.[J].Front Oncol,2022,12(null):712475. [30] CAI W,XU Y,YIN J,et al.miR-552-5p facilitates osteosarcoma cell proliferation and metastasis by targeting WIF1.[J].EXP THER MED,2019,17(5):3781-3788. [31] HUANG M,LIAO X,LI L,et al.MiR-552-3p facilitated cell proliferation,migration and invasion by sponging Fibulin 5 in non-small cell lung cancer via activation of ERK/GSK3β/β-catenin signaling pathway.[J].TISSUE CELL,2021,73(null):101672.
Full Text:
DOI